{"id":"https://openalex.org/A5084864633","orcid":null,"observed_orcids":[],"display_name":"Takuya Okagaki","raw_author_names":["Okagaki, Takuya","TAKUYA OKAGAKI","Takuya Okagaki"],"full_name":"TAKUYA OKAGAKI","works_count":7,"cited_by_count":195,"summary_stats":{"2yr_mean_citedness":1.0,"h_index":2,"i10_index":1},"ids":{"openalex":"https://openalex.org/A5084864633","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210128940","ror":"https://ror.org/030z9kz64","display_name":"UCB Pharma (Japan)","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210128940","https://openalex.org/I85722119"]},"years":[2024,2014]},{"institution":{"id":"https://openalex.org/I4387155982","ror":"https://ror.org/038ehsm73","display_name":"Tanabe Pharma Corporation (Japan)","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]},"years":[1998]},{"institution":{"id":"https://openalex.org/I85722119","ror":"https://ror.org/01n029866","display_name":"UCB Pharma (Belgium)","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]},"years":[2024]}],"last_known_institutions":[{"id":"https://openalex.org/I4210128940","ror":"https://ror.org/030z9kz64","display_name":"UCB Pharma (Japan)","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210128940","https://openalex.org/I85722119"]},{"id":"https://openalex.org/I85722119","ror":"https://ror.org/01n029866","display_name":"UCB Pharma (Belgium)","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","count":3,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","count":3,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":2,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","count":1,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","count":1,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","value":2e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","value":1.17e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","value":1.07e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","value":8.2e-06,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","value":5.3e-06,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.8819183707237244},{"id":"112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","score":0.8241999745368958},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.7493000030517578},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.3127671480178833},{"id":"127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","score":0.1023980975151062}],"counts_by_year":[{"year":1988,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":1998,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2005,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":17},{"year":2013,"works_count":0,"oa_works_count":0,"cited_by_count":12},{"year":2014,"works_count":1,"oa_works_count":0,"cited_by_count":12},{"year":2015,"works_count":1,"oa_works_count":0,"cited_by_count":11},{"year":2016,"works_count":0,"oa_works_count":0,"cited_by_count":3},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":8},{"year":2018,"works_count":0,"oa_works_count":0,"cited_by_count":4},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":7},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":3},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":3},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":5},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":5},{"year":2024,"works_count":2,"oa_works_count":2,"cited_by_count":4},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":2},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":1}],"display_name_alternatives":["Okagaki, Takuya","TAKUYA OKAGAKI","Takuya Okagaki"],"block_key":"t okagaki","works_api_url":"https://api.openalex.org/works?filter=author.id:A5084864633","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2016-06-24T00:00:00"}